Abstract: A liquid composition, including component (a): at least one peptide aldehyde, and component (b): at least two organic solvents, where one organic solvent is 1,2-propane diol and at least one further organic solvent is selected from the group consisting of diols other than 1,2-propane diol in a weight ratio of 1,2-propane diol: at least one diol other than 1,2-propane diol of 25:1 to 1:4.

Abstract: Described herein is a liquid composition including at least component (a) a polymer which is (a1) an ethoxylated hexamethylene diamine polymer, quaternized and optionally sulfated including on average 20 to 30 ethoxylate groups (EO) with an average molecular weight Mw in a range from 2,000 to 10,000 g/mol and mixtures thereof, and/or (a2) an ethoxylated polyethylenimine including on average 15 to 25 ethoxylate groups (EO) per NH-group with an average molecular weight MW in a range from 5,000 to 20,000 g/mol; and component (b) at least one cellulase.

Abstract: The present invention relates to a computer-implemented method for activity based chemical substance formulation management of a chemical substance formulation comprising (i) receiving input data, preferably via an input unit (10), of at least one storage segment data defined by at least temperature and storage duration and an initial chemical substance activity value of said chemical substance formulation; (ii) determining, specifically calculating, a remaining activity value of the chemical substance formulation based on the storage segment data and the initial chemical substance activity value via a processing unit (20); (iii) providing a remaining activity value for the chemical substance formulation, preferably via an output unit (30), and (iv) managing said chemical substance formulation based on the remaining activity value of step (iii), said managing preferably comprising at least one of —providing a dosage recommendation based on the remaining activity value of the chemical substance formulation, pr

Abstract: Provided are compositions that include a metal-organic framework (MOF) including a framework defining an internal volume, an enzyme disposed within the internal volume, and a surfactant. Also provided are methods of making the compositions and their use.

Abstract: The present invention relates to a computer-implemented method for activity based enzyme formulation management of an enzyme formulation comprising (i) receiving input data, preferably via an input unit (10), of at least one storage segment data defined by at least temperature and storage duration and an initial enzyme activity value of said enzyme Predicted degradation formulation; (ii) determining, specifically calculating, a remaining activity value of the enzyme formulation based on the storage segment data and the initial enzyme activity value via a processing unit (20); (iii) providing a remaining activity value for the enzyme formulation, preferably via an output unit (30), and (iv) managing said enzyme formulation based on the remaining activity value of step (iii), said managing preferably comprising at least one of—providing a dosage recommendation based on the remaining activity value of the enzyme formulation, preferably via an output unit (30);—providing a residual shelf life indicator for said e

Abstract: Polymer capsule comprising at least one polymer P1 and at least one microorganism M, wherein said polymer P1 has a solubility in water at 21° C. of at least 1 g/l and wherein said polymer capsule has an average particle size d90 of below 100 ?m, wherein said microorganism M is distributed throughout said capsule.

Abstract: Described herein is an enzyme preparation including component (a): at least one compound according to general formula (I) wherein R1 is; R2, R3, R4 are independently from each other selected from the group consisting of H, linear C1-C8 alkyl, and branched C3-C8 alkyl, C6-C10-aryl, non-substituted or substituted with one or more carboxylate or hydroxyl groups, and C6-C10-aryl-alkyl, wherein an alkyl of the C6-C10-aryl-alkyl is selected from the group consisting of linear C1-C8 alkyl and branched C3-C8 alkyl, wherein at least one of R2, R3, and R4 is not H, component (b): at least one enzyme selected from the group consisting of hydrolases (EC 3); and optionally component (c): at least one compound selected from the group consisting of solvents, enzyme stabilizers different from component (a), and compounds stabilizing the enzyme preparation.

Abstract: Described herein is an enzyme preparation including component (a): at least one compound according to general formula (I) wherein R1 is H; R2, R3, R4 are independently from each other selected from the group consisting of H, linear C1-C8 alkyl, and branched C3-C8 alkyl, C6-C10-aryl, non-substituted or substituted with one or more carboxylate or hydroxyl groups, and C6-C10-aryl-alkyl, wherein an alkyl of the C6-C10-aryl-alkyl is selected from the group consisting of linear C1-C8 alkyl and branched C3-C8 alkyl, wherein at least one of R2, R3, and R4 is not H; component (b): at least one enzyme selected from the group consisting of hydrolases (EC 3); and optionally component (c): at least one compound selected from the group consisting of solvents, enzyme stabilizers different from component (a), and compounds stabilizing the enzyme preparation.

Abstract: The present invention relates to a test element for the detection of an analyte comprising an enzyme, wherein the enzyme is incorporated in a nanocapsule.

Abstract: The present invention relates to a test element for the detection of an analyte comprising an enzyme, wherein the enzyme is incorporated in a nanocapsule.

Abstract: Composition containing (A) at least one salt of an organic ester of choline or of a derivative of choline, and (B) at least one surfactant selected from amphoteric and anionic and non-ionic surfactants.

Abstract: The present invention relates to a test element for the detection of an analyte comprising an enzyme, wherein the enzyme is incorporated in a nanocapsule.